Sexual Dysfunction After Renal Transplantation
Sponsor
Xijing Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT05856929
Collaborator
(none)
500
2
20
250
12.5
Study Details
Study Description
Brief Summary
A questionnaire will be send to kidney transplant recipients to investigate characteristics of them and their sexual function, all participants in the survey are anonymous and voluntary, then analyse these characteristics.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Study Type:
Observational
Anticipated Enrollment
:
500 participants
Observational Model:
Other
Time Perspective:
Cross-Sectional
Official Title:
Sexual Function and Reproductive Function of Kidney Transplant Recipients
Actual Study Start Date
:
Oct 1, 2022
Anticipated Primary Completion Date
:
Jan 1, 2024
Anticipated Study Completion Date
:
Jun 1, 2024
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Renal transplant group
|
Other: no Intervention
no intervention
|
Outcome Measures
Primary Outcome Measures
- the number of participants is up to 500 [2024.06]
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
- patients who have undergone kidney transplantation for more than six months
Exclusion Criteria:
- having no sexual partner, being under 18 or over 70 years of age, exhibiting abnormal mental behavior, having poor understanding and communication ability, having low intelligence, or having a congenital sexual disorder
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Xijing Hospital | Xi'an | Shaanxi | China | 710032 |
2 | Department of Urology | Xi'an | China | 710032 |
Sponsors and Collaborators
- Xijing Hospital
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Xijing Hospital
ClinicalTrials.gov Identifier:
NCT05856929
Other Study ID Numbers:
- KY20222236-C-1
First Posted:
May 12, 2023
Last Update Posted:
May 12, 2023
Last Verified:
Sep 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
No